Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging  Stephen C. Lenhard, M.S., Robin E. Haimbach, B.S.,

Slides:



Advertisements
Similar presentations
Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis  Paul J. Hoffman, B.S., Dawn B. Milliken,
Advertisements

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.
Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection  Na Huang, M.S., Bing Situ, M.S., Xiao.
Complete septate uterus with longitudinal vaginal septum
Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States  Ahmed M. Soliman, Ph.D., M.S., Hugh Taylor, M.D.,
Age at menarche: a predictor of diminished ovarian function?
Fertility after bilateral uterine artery embolization in a sheep model
Anton Langebrekke, M.D., Erik Qvigstad, M.D., Ph.D. 
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center  Min Zhou, M.D., Ph.D., Jin-Yun.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Christian M. Becker, M. D. , David A. Sampson, B. A. , Maria A
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Expression and localization of transcription factor Ets-1 in the rat ovary during the estrous cycle and pregnancy  Xiaohui Xiao, M.S., Aiqin Liu, Ph.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Isabel Cerveira, M. D. , Cristina Costa, M. D. , Fernando Santos, M. D
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Medical treatment of ectopic pregnancy: a committee opinion
Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain  David S. Guzick, M.D.,
Live birth of twins derived from zona-free oocytes
Aberrant implantation and growth of uterine leiomyoma in the abdominal wall after laparoscopically assisted myomectomy  Osamu Wada-Hiraike, M.D., Ph.D.,
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
A comparison of blood spot vs
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Florid endometriosis in a postmenopausal woman
Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles  Tsung-Hsien.
Oocyte cryopreservation
Efficacy of tibolone as “add-back therapy” in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids  Edward.
Intraoperative and postoperative lower genital tract changes after global endometrial ablation using the Hydro ThermAblator® device  Martin Farrugia,
Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D
Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A
With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?  Jacques Donnez, M.D., Ph.D., Olivier.
A prospective study of early pregnancy loss in humans
Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged.
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Should embryos developing to blastocysts on day 7 be cryopreserved and transferred: an analysis of pregnancy and implantation rates  George Kovalevsky,
Introduction Fertility and Sterility
Esther V. A. Bouwsma, M. D. , Krzysztof R. Gorny, Ph. D. , Gina K
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract  Kimberly D. Coleman, M.S., Jacqueline A. Wright,
Image-guided drainage versus antibiotic-only treatment of pelvic abscesses: short-term and long-term outcomes  Justin To, M.D., Diana Aldape, M.D., Andrei.
Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting  Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.
Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short- antagonist protocol: a prospective cohort study  Shweta Nayak,
GnRH antagonists may affect endometrial receptivity
Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D. 
A randomized trial of excision versus ablation for mild endometriosis
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease  Idhaliz Flores, Ph.D., Elizabeth Rivera,
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
Fertility and Sterility: an evaluation
Counteraction during movement of spermatozoa by Trichomonas vaginalis observed by visual image analysis: a possible cause of female infertility  Viroj.
Rachana V. Garde, M. D. , Vuk P. Jovanovic, M. D. , Grace M
Genetic evaluation procedures at sperm banks in the United States
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist 
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Adrienne B. Neithardt, M. D. , James H. Segars, M. D
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Endometrial polyps affect uterine receptivity
Presentation transcript:

Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging  Stephen C. Lenhard, M.S., Robin E. Haimbach, B.S., Anthony C. Sulpizio, B.S., David P. Brooks, Ph.D., Jeffrey D. Bray, Ph.D., Beat M. Jucker, Ph.D.  Fertility and Sterility  Volume 88, Issue 4, Pages 1058-1064 (October 2007) DOI: 10.1016/j.fertnstert.2006.11.164 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Estrous pattern displayed by low activity periods. Nocturnal low activity periods (<21 activity counts/15-min period) were collected for 1 month and coincide with the 4-day estrous cycle. Each trough corresponds to the night before a day of estrus. Lenhard. MRI of implanted uterine tissue in rat. Fertil Steril 2007. Fertility and Sterility 2007 88, 1058-1064DOI: (10.1016/j.fertnstert.2006.11.164) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Early ectopic uterine tissue (EUT) development. The magnetic resonance images (MRI) of early EUT growth in the same rat from day of transplantation surgery (day 0) through to day 4 after surgery are shown (A). A magnified view of the EUT attachment to the peritoneal wall may be observed in the figure inset. Mean daily EUT volume increased 54%, 117%, 220%, and 279%, respectively, from day 1 through day 4 after surgery versus day 0 (B). Data are presented as mean ± SEM. ∗P<.001 vs. day 0. Lenhard. MRI of implanted uterine tissue in rat. Fertil Steril 2007. Fertility and Sterility 2007 88, 1058-1064DOI: (10.1016/j.fertnstert.2006.11.164) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Effect of ovariectomy on EUT volume. (A) MRIs of the same representative rat's preovariectomy and 2 weeks postovariectomy EUT. The EUT volumes decreased after ovariectomy and achieved a plateau volume at approximately 6 weeks after ovariectomy (n = 6) (B). Data are presented as mean ± SEM. ∗P<.05, ∗∗P<.01, †P<.001 vs. baseline. Lenhard. MRI of implanted uterine tissue in rat. Fertil Steril 2007. Fertility and Sterility 2007 88, 1058-1064DOI: (10.1016/j.fertnstert.2006.11.164) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Effect of Antide on EUT volume with or without hormone supplementation. The MRIs were acquired of the transplanted EUT at baseline (n = 12). Antide (GnRH antagonist) was administered every 3 days for 12 days at 2 mg/kg/day. After 12 days on Antide, rats were divided into two groups to receive hormone supplementation with either 17β-E2 (0.08 mg/kg/day, n = 6) or P (4.0 mg/kg/day, n = 6). Antide treatment significantly reduced EUT volumes, whereas 17β- E2 supplementation significantly increased EUT volumes after 4 and 8 days of treatment. Progesterone supplementation did not affect EUT volumes at either time point. Data are presented as mean ± SEM. ∗P<.0001 vs. baseline; ∗∗P<.05 vs. Antide. Lenhard. MRI of implanted uterine tissue in rat. Fertil Steril 2007. Fertility and Sterility 2007 88, 1058-1064DOI: (10.1016/j.fertnstert.2006.11.164) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 5 The MRI assessment of transplanted EUT perfusion characteristics. MRIs of an established EUT (∼5 weeks after transplantation) pre (A) and ∼2 minutes after bolus injection of Gd-DTPA contrast agent (B). Early EUT growth and perfusion was monitored by imaging immediately after bolus injections of Gd-DTPA on the day of EUT transplantation (day 0) (C) and at 3 days after transplantation (D). Lenhard. MRI of implanted uterine tissue in rat. Fertil Steril 2007. Fertility and Sterility 2007 88, 1058-1064DOI: (10.1016/j.fertnstert.2006.11.164) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions